Nadia Harbeck explains why the IMpassion031 results cement the role of neoadjuvant immunotherapy plus chemotherapy in early-stage triple-negative breast cancer (2:54).
20-09-2020 | ESMO 2020 | Conference coverage | Video
20-09-2020 | ESMO 2020 | Conference coverage | Video
Nadia Harbeck explains why the IMpassion031 results cement the role of neoadjuvant immunotherapy plus chemotherapy in early-stage triple-negative breast cancer (2:54).